Earnest Partners LLC Bio Rad Laboratories, Inc. Transaction History

Earnest Partners LLC

  • $21.2 Billion
  • Q1 2024

A detailed history of Earnest Partners LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Earnest Partners LLC holds 514,906 shares of BIO stock, worth $141 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
514,906
Previous 393,634 30.81%
Holding current value
$141 Million
Previous $127 Million 40.12%
% of portfolio
0.84%
Previous 0.65%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$304.11 - $351.99 $36.9 Million - $42.7 Million
121,272 Added 30.81%
514,906 $178 Million
Q4 2023

Feb 14, 2024
BUY
$269.37 - $365.04 $11.3 Million - $15.4 Million
42,124 Added 11.98%
393,634 $127 Million
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $25.1 Million - $30.2 Million
71,570 Added 25.57%
351,510 $126 Million
Q2 2023

Aug 07, 2023
BUY
$359.49 - $486.4 $9.52 Million - $12.9 Million
26,476 Added 10.45%
279,940 $106 Million
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $3.57 Million - $4.29 Million
8,519 Added 3.48%
253,464 $121 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $5.02 Million - $6.5 Million
14,265 Added 6.18%
244,945 $103 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $2.67 Million - $3.64 Million
6,464 Added 2.88%
230,680 $96.2 Million
Q2 2022

Aug 12, 2022
BUY
$463.67 - $597.16 $15 Million - $19.3 Million
32,275 Added 16.82%
224,216 $111 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $713,415 - $1 Million
1,360 Added 0.71%
191,941 $108 Million
Q4 2021

Feb 07, 2022
BUY
$708.84 - $794.68 $13.1 Million - $14.6 Million
18,419 Added 10.7%
190,581 $144 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $1.48 Million - $1.86 Million
-2,257 Reduced 1.29%
172,162 $128 Million
Q2 2021

Aug 16, 2021
BUY
$576.64 - $649.04 $4.27 Million - $4.81 Million
7,410 Added 4.44%
174,419 $112 Million
Q1 2021

May 17, 2021
BUY
$547.01 - $662.35 $8.5 Million - $10.3 Million
15,547 Added 10.26%
167,009 $95.4 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $4.23 Million - $5.33 Million
8,286 Added 5.79%
151,462 $88.3 Million
Q3 2020

Nov 16, 2020
BUY
$454.43 - $535.6 $4.9 Million - $5.77 Million
10,780 Added 8.14%
143,176 $73.8 Million
Q2 2020

Aug 13, 2020
BUY
$334.87 - $493.06 $2.87 Million - $4.22 Million
8,558 Added 6.91%
132,396 $59.8 Million
Q1 2020

May 14, 2020
BUY
$320.01 - $409.07 $919,068 - $1.17 Million
2,872 Added 2.37%
123,838 $43.4 Million
Q4 2019

Feb 07, 2020
BUY
$319.73 - $374.2 $4.12 Million - $4.82 Million
12,889 Added 11.93%
120,966 $44.8 Million
Q3 2019

Nov 14, 2019
BUY
$304.55 - $345.24 $52,991 - $60,071
174 Added 0.16%
108,077 $36 Million
Q2 2019

Aug 13, 2019
BUY
$286.93 - $312.59 $1.47 Million - $1.6 Million
5,111 Added 4.97%
107,903 $33.7 Million
Q1 2019

May 15, 2019
SELL
$224.3 - $317.41 $364,711 - $516,108
-1,626 Reduced 1.56%
102,792 $31.4 Million
Q4 2018

Feb 14, 2019
BUY
$220.1 - $309.0 $36,096 - $50,676
164 Added 0.16%
104,418 $24.2 Million
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $714,810 - $805,916
-2,471 Reduced 2.32%
104,254 $32.6 Million
Q2 2018

Aug 13, 2018
SELL
$244.1 - $303.88 $569,241 - $708,648
-2,332 Reduced 2.14%
106,725 $30.8 Million
Q1 2018

May 15, 2018
SELL
$233.97 - $274.11 $58,492 - $68,527
-250 Reduced 0.23%
109,057 $27.3 Million
Q4 2017

Feb 14, 2018
SELL
$216.94 - $271.3 $1.19 Million - $1.48 Million
-5,464 Reduced 4.76%
109,307 $26.1 Million
Q3 2017

Nov 14, 2017
SELL
$212.27 - $242.28 $521,759 - $595,524
-2,458 Reduced 2.1%
114,771 $25.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
117,229
117,229 $26.5 Million

Others Institutions Holding BIO

# of Institutions
489
Shares Held
17.8M
Call Options Held
44.9K
Put Options Held
79.7K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.73B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Earnest Partners LLC Portfolio

Follow Earnest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Earnest Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email